Large Volume Parenteral (LVP) Market Report 2026

Large Volume Parenteral (LVP) Market Overview

• Large Volume Parenteral (LVP) market size has reached to $13.53 billion in 2025 • Expected to grow to $21.37 billion in 2030 at a compound annual growth rate (CAGR) of 9.7% • Growth Driver: Large-Volume Parenteral Market Thrives On The Surge In Chronic Diseases • Market Trend: Smart Infusion Devices Driving Safety And Efficiency In LVP Administration • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Large Volume Parenteral (LVP) Market?

Large volume parenteral (LVP) refers to sterile intravenous solutions of a volume of 100 ml or more that are terminally sterilized by heat. They are used for intravenous infusions to administer hydration, nourishment, and medicine. The main large-volume parenteral (LVP) types are soft bag LVP, plastic bag LVP, and glass bottle LVP. Soft bag LVP refers to a flexible bag filled with sterilized IV solutions that are used in medical settings to provide patients with fluids and drugs. The various volumes are 100 ml - 250 ml, 250 ml - 500 ml, 500 ml - 1000 ml, 1000 ml -2000 ml, and 2000 and more applied for basic infusion, therapeutics infusion, and nutritious infusion. The end users are hospitals, medical centers, and others.

What Is The Large Volume Parenteral (LVP) Market Growth Forecast?

The large volume parenteral (lvp) market size is expected to see strong growth in the next few years. It will grow to $21.37 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to aging population growth, rising prevalence of chronic diseases, increasing demand for parenteral nutrition, expansion of healthcare infrastructure in emerging markets, growth in emergency and trauma care services. Major trends in the forecast period include growing demand for non-pvc and eco-friendly lvp packaging, expansion of ready-to-use and premixed infusion solutions, increasing focus on sterility and contamination control, rising use of lvps in critical care and emergency medicine, growth in hospital-based infusion therapy volumes.

Global Large Volume Parenteral (LVP) Market Segmentation

1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP 2) By Volume: 100 ML - 250 ML, 250 ML - 500 ML, 500 ML - 1000 ML, 1000 ML -2000 ML, 2000 And More 3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion 4) By End-User: Hospital, Medical Centers, Other End Users Subsegments: 1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags 2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags 3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles

What Are The Drivers Of The Large Volume Parenteral (LVP) Market?

The growing prevalence of chronic diseases is expected to propel the growth of the large-volume parenteral market going forward. Chronic diseases refer to a sickness or condition that typically lasts three months or longer and can potentially worsen over time. The rise in chronic diseases is mainly driven by tobacco use, being around smoke, and poor nutrition. These patients must require an appropriate ratio of essential nutrients that support the maintenance of strength, and the parenteral mode of administration facilitates the correct pharmaceutical dosage because most of the drug is directly absorbed in circulation, skipping the digestive system. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. Therefore, the growing prevalence of chronic diseases drives the growth of the large-volume parenteral market. The increasing healthcare expenditure is expected to propel the growth of the large-volume parenteral market going forward. Healthcare expenditure referred as rising amount of money spent on healthcare services and related activities, such as health research and public health. Higher healthcare expenditure is often associated with the development and expansion of healthcare infrastructure. This includes the construction of new hospitals, clinics, and healthcare facilities. With improved infrastructure, there is a greater capacity to provide medical services, contributing to the demand for LVP solutions. For instance, in April 2025, according to the American Medical Association, a US-based professional association, health spending in the U.S. rose by 7.5% in 2023 to reach $4.9 trillion, or $14,570 per person, marking a notable increase compared to the 4.6% growth recorded in 2022. Therefore, the increasing healthcare expenditure drives the growth of the large-volume parenteral market.

Key Players In The Global Large Volume Parenteral (LVP) Market

Major companies operating in the large volume parenteral (lvp) market are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Otsuka Holdings Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Grifols S.A., Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd., Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd., Pentagon Labs Ltd., DJ Labs Pvt. Ltd., Higgs Healthcare

Global Large Volume Parenteral (LVP) Market Trends and Insights

Major companies operating in the large volume parenteral (LVP) market are focusing on developing smart infusion‑device innovations, such as intelligent large‑volume infusion pumps, to meet the rising demand for safer, more automated, and connected intravenous therapy driven by increasing hospital-based infusion services, remote patient monitoring, and the push toward standardized, error‑resistant medication delivery. An intelligent large‑volume infusion pump is a device designed to deliver high‑volume IV fluids (LVP) with integrated dose‑error reduction software, connectivity for smart drug libraries, and alarm management unlike traditional infusion pumps that rely solely on manual programming and limited automation, these next-generation pumps help prevent dosing mistakes, reduce workflow burden, and integrate with hospital IT systems. For instance, in April 2024, Baxter International Inc., a US-based pharmaceutical and medical-device company, received U.S. FDA clearance for its Novum IQ Large‑Volume Infusion Pump with Dose IQ smart-dose software. The device supports high-rate fluid delivery, including large-volume infusions, offers safety features such as drug library integration to minimize dosing errors, and allows connectivity to hospital electronic medical records and smart monitoring platforms. By enabling safe, automated, and worry-free infusion of large volumes, the Novum IQ pump helps healthcare providers improve infusion accuracy, reduce the risk of dosing mistakes, and streamline high‑volume IV therapy workflows.

Regional Outlook

North America was the largest region in the large volume parenteral (LVP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Large Volume Parenteral (LVP) Market?

The large-volume parenteral (LVP) market consists of sales of sterile intravenous solutions, peritoneal dialysis solutions, plasma substitutes, and sterile powders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Large Volume Parenteral (LVP) Market Report 2026?

The large volume parenteral (lvp) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the large volume parenteral (lvp) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.